Literature DB >> 8025761

Chronic destructive lung disease associated with a novel mycobacterium.

S Emler1, T Rochat, P Rohner, C Perrot, R Auckenthaler, L Perrin, B Hirschel.   

Abstract

A woman born in 1920 has suffered from a chronic destructive lung disease since 1972, with development of a severe combined restrictive and obstructive ventilatory defect. Large quantities of acid-fast microorganisms have been repeatedly observed in her sputum. Multiple courses of antimycobacterial treatment did not stop the progression of the disease. The mycobacterium involved was first identified as Mycobacterium gordonae, and later as Mycobacterium scrofulaceum. Analysis of part of the amplified gene of the 16S rRNA, however, revealed that its sequence differed from that of any established mycobacterial species, although it was observed once before in a German lymph node isolate, for which the name "Mycobacterium interjectum" has been proposed. Retrospective analysis confirmed the presence of this sequence in frozen samples which had been provided by the patient in 1983, 1985, 1989, 1990, and 1993. Our case confirms the value of amplification and sequencing of mycobacterial 16S rRNA for classifying mycobacteria, and suggests that "Mycobacterium interjectum" may be involved in cases of chronic destructive lung disease.

Entities:  

Mesh:

Year:  1994        PMID: 8025761     DOI: 10.1164/ajrccm.150.1.8025761

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Mycobacterium interjectum as causative agent of cervical lymphadenitis.

Authors:  T De Baere ; M Moerman; L Rigouts; C Dhooge; H Vermeersch; G Verschraegen; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study.

Authors:  P Kirschner; J Rosenau; B Springer; K Teschner; K Feldmann; E C Böttger
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo.

Authors:  S Ehlers; E Richter
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

4.  Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum.

Authors:  R Lumb; A Goodwin; R Ratcliff; R Stapledon; A Holland; I Bastian
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 5.  Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Disseminated Mycobacterium interjectum Infection with Bacteremia, Hepatic and Pulmonary Involvement Associated with a Long-Term Catheter Infection.

Authors:  David Sotello; D Jane Hata; Mohammed Reza; Raj Satyanarayana; Vichaya Arunthari; Wendelyn Bosch
Journal:  Case Rep Infect Dis       Date:  2017-01-18

7.  Mycobacterium interjectum Lung Infection.

Authors:  M C Mirant-Borde; S Alvarez; M M Johnson
Journal:  Case Rep Pulmonol       Date:  2013-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.